NewslettersESC & iPSC NewsPancreatic Cell NewsManufacturing Clinical-Grade Human Induced Pluripotent Stem Cell-Derived Beta Cells for Diabetes TreatmentBy lbeveridge - April 27, 20220325Investigators focus on the key processes and guidelines for clinical translation of hPSC-derived β cells for diabetes cell therapy.[Cell Proliferation]Full Article